GlassScriptPhysician profile
Justin James Taylor
NPI 1518718063
$1,647.94
in general payments reported to CMS, 2019-2025
9 companies · $1,265 in 2025
The $1,265 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $383 · 2025: $1,265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,647.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $431.98 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Musculoskeletal Transplant Foundation INC. | $266.62 | 2025 | |
| Abbvie INC. | $232.07 | 2025 | |
| Tela Bio, INC. | $174.06 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $162.63 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Davol INC. | $141.85 | 2024 | Phasix Mesh |
| Axogen | $119.12 | 2025 | |
| Sanara Medtech INC. | $110.19 | 2024 | Celleraterx |
| Skeletal Dynamics INC | $9.42 | 2024 | Ijs, Implate, Geminus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.